Analysis reveals distinct gut microbiota changes in granulomatous mastitis, highlighting pathogenesis and treatment potential.
GM demonstrates distinct microbial signatures, including pro-inflammatory taxa enrichment and protective commensal depletion, along with systemic dysbiosis. These findings support a microbiota-driven pathogenesis and highlight the potential of microbial biomarkers and therapeutic modulation.
No takes yet. Share an insight, caveat, or question.
Deniz Sünnetçi Akkoyunlu (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: